Table 1.
Variable | Number of patients (n = 176) | Arpin expression | P‐value | |
---|---|---|---|---|
High (n = 56) | Low (n = 120) | |||
Age | ||||
>50 | 79 | 26 | 53 | 0.779 |
<50 | 97 | 30 | 67 | |
Lymph node metastasis | ||||
Yes | 88 | 16 | 72 | <0.001 |
No | 88 | 40 | 48 | |
TNM stage | ||||
I | 72 | 32 | 40 | 0.003 |
II | 52 | 16 | 36 | |
III | 52 | 8 | 44 | |
Grade | ||||
1 | 14 | 2 | 12 | 0.065 |
2 | 68 | 28 | 40 | |
3 | 94 | 26 | 68 | |
OR | ||||
Positive | 122 | 34 | 88 | 0.091 |
Negative | 54 | 22 | 32 | |
PR | ||||
Positive | 132 | 36 | 96 | 0.025 |
Negative | 44 | 20 | 24 | |
Her‐2 | ||||
Positive | 26 | 6 | 20 | 0.3 |
Negative | 150 | 50 | 100 | |
Ki‐67 | ||||
Positive | 66 | 20 | 46 | 0.738 |
Negative | 110 | 36 | 74 | |
Diameter | ||||
≥2 | 52 | 12 | 40 | 0.107 |
<2 | 124 | 44 | 80 |
Ki‐67 ≤ 20%: Negative.
Ki‐67 > 20%: Positive.
TNM: tumour, nodes, metastasis system; OR: oestrogen receptor; PR: progesterone receptor.